Your browser doesn't support javascript.
loading
Vitamin D metabolic pathway genes and pancreatic cancer risk.
Arem, Hannah; Yu, Kai; Xiong, Xiaoqin; Moy, Kristin; Freedman, Neal D; Mayne, Susan T; Albanes, Demetrius; Arslan, Alan A; Austin, Melissa; Bamlet, William R; Beane-Freeman, Laura; Bracci, Paige; Canzian, Federico; Cotterchio, Michelle; Duell, Eric J; Gallinger, Steve; Giles, Graham G; Goggins, Michael; Goodman, Phyllis J; Hartge, Patricia; Hassan, Manal; Helzlsouer, Kathy; Henderson, Brian; Holly, Elizabeth A; Hoover, Robert; Jacobs, Eric J; Kamineni, Aruna; Klein, Alison; Klein, Eric; Kolonel, Laurence N; Li, Donghui; Malats, Núria; Männistö, Satu; McCullough, Marjorie L; Olson, Sara H; Orlow, Irene; Peters, Ulrike; Petersen, Gloria M; Porta, Miquel; Severi, Gianluca; Shu, Xiao-Ou; Visvanathan, Kala; White, Emily; Yu, Herbert; Zeleniuch-Jacquotte, Anne; Zheng, Wei; Tobias, Geoffrey S; Maeder, Dennis; Brotzman, Michelle; Risch, Harvey.
Afiliação
  • Arem H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Xiong X; Information Management Systems, Inc., Calverton, Maryland, United States of America.
  • Moy K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Mayne ST; Yale School of Public Health/Yale Cancer Center, New Haven, Connecticut, United States of America.
  • Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Arslan AA; Departments of Population Health, Obstetrics and Gynecology (Obs/Gyn) and Environmental Medicine, New York University, New York, New York, United States of America.
  • Austin M; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
  • Bamlet WR; Department of Epidemiology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Beane-Freeman L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Bracci P; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America.
  • Canzian F; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cotterchio M; Dalla Lana School of Public Health, University of Toronto; Prevention and Cancer Control, Cancer Care Ontario Toronto, Ontario, Canada.
  • Duell EJ; Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Gallinger S; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
  • Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria and Centre for MEGA Epidemiology, School of Population Health, the University of Melbourne, Melbourne, Australia.
  • Goggins M; Departments of Oncology, Pathology and Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Goodman PJ; Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio, United States of America.
  • Hartge P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Hassan M; Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Helzlsouer K; MD Mercy, Baltimore, Maryland, United States of America.
  • Henderson B; Department of Preventative Medicine, School of Medicine, University of Southern California, Los Angeles, California, United States of America.
  • Holly EA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America.
  • Hoover R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Jacobs EJ; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America.
  • Kamineni A; GroupHealth Research Institute, Seattle, Washington, United States of America.
  • Klein A; MD Mercy, Baltimore, Maryland, United States of America.
  • Klein E; Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio, United States of America.
  • Kolonel LN; University of Hawaii Cancer Center, Manoa, Hawaii, United States of America.
  • Li D; Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Malats N; Molecular Pathology Program, Spanish National Cancer Research Center, Madrid, Spain.
  • Männistö S; National Institute for Health and Welfare, Department of Chronic Disease Prevention, Helsinki, Finland.
  • McCullough ML; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America.
  • Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
  • Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
  • Peters U; Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio, United States of America.
  • Petersen GM; Department of Epidemiology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Porta M; Hospital del Mar Institute of Medical Research (IMIM), and School of Medicine, Barcelona Spain.
  • Severi G; Cancer Epidemiology Centre, Cancer Council Victoria and Centre for MEGA Epidemiology, School of Population Health, the University of Melbourne, Melbourne, Australia.
  • Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Visvanathan K; MD Mercy, Baltimore, Maryland, United States of America.
  • White E; Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio, United States of America.
  • Yu H; University of Hawaii Cancer Center, Manoa, Hawaii, United States of America.
  • Zeleniuch-Jacquotte A; Departments of Population Health, Obstetrics and Gynecology (Obs/Gyn) and Environmental Medicine, New York University, New York, New York, United States of America.
  • Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Tobias GS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Maeder D; Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Brotzman M; Westat, Rockville, Maryland, United States of America.
  • Risch H; Yale School of Public Health/Yale Cancer Center, New Haven, Connecticut, United States of America.
PLoS One ; 10(3): e0117574, 2015.
Article em En | MEDLINE | ID: mdl-25799011

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Vitamina D / Biomarcadores Tumorais / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Redes e Vias Metabólicas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Vitamina D / Biomarcadores Tumorais / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Redes e Vias Metabólicas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos